Surgery, Gastroenterology and Oncology
Vol. 23, No. 2, Apr 2018
Strategies and Techniques for the Treatment of Concomitant Gallbladder and Common Bile Duct Stones: An Economic Dilemma Only?
Antonio Zanghi, Andrea Cavallaro, Sergio Castorina, Maria Di Vita, Laura Fisichella, Francesco Cardi, Fabio Melandro, Alessia Giaquinta, Alessandro Cappellani
ORIGINAL PAPER, Apr 2018
Article DOI: 10.21614/sgo-23-2-127
Background: Single stage laparoendoscopic rendez-vous (LERV), single-stage laparoscopic common bile duct exploration - cholecystectomy (LCBDE), and two-stage endolaparoscopic (LC-ERCP) management of cholecystocholedocholithiasis can be performed with similar short and long-term outcomes. This multicentric study retrospectively examined the outcome and hospital costs of one-stage vs. sequential two-stage strategies of treatment.

Methods: From January 2013 to December 2016, all the patients affected by cholecystocholedocholithiasis and treated at 2 different medical centers (General surgery and senology Unit - Policlinico Vittorio Emanuele Hospital and G.B. Morgagni Hospital, Catania - Italy) were enrolled in a retrospective study. Measures of outcome were hospital costs, postoperative morbidity and length of hospital stay. The 3 different approaches to cholecystocholedocholithiasis were retrospectively compared: two-stage endolaparoscopic (LC-ERCP) (Group A), laparoendoscopic rendez-vous (LERV) (Group B), and laparoscopic common bile duct exploration (LCBDE) (Group C) that includes laparoscopic trans-cystic common bile duct exploration (LTC-CBDE) and laparoscopic direct common bile duct exploration (LD-CBDE)

Results: A total of 204 patients met the study criteria. One-stage laparoscopic management using a direct common bile duct exploration approach (LD-CBDE) was the least expensive option when compared to LTC-CBDE (LTC-CBDE 1480 versus LD-CBDE 1264, p < 0.001). However, two-stage LC-ERCP appears to be, according to our experience, the least expensive of all (998 ). The rendezvous technique group demonstrated a better overall efficacy with a complete clearance of the bile duct in 100% of the cases, as compared to the 80% of the LCERCP group and 72% of the LCBDE. Postoperative morbidity was 5% in the LC-ERCP group versus 9.75% in the LERV group, and 3.12% in the LCBDE group, respectively. The average length of hospital stay was 7.7 days and 17, and 11.8 days in the LERV, LCBDE, and LCERCP, respectively.

Conclusions: According to our experience, the Rendezvous technique provides the best strategy for the treatment of cholecystocholedocholithiasis in terms of clearance of the biliary duct, hospital stay, morbidity and costs. Randomized trials should be designed to confirm these findings.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 3222


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.